{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:05Z","timestamp":1761975365044},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/wno.0b013e31828ea2fc","type":"journal-article","created":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T14:14:50Z","timestamp":1366467290000},"page":"143-148","source":"Crossref","is-referenced-by-count":6,"title":["Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod"],"prefix":"10.1097","volume":"33","author":[{"given":"Xiaoming","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kezuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimichi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusaku","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210126","doi-asserted-by":"crossref","first-page":"294046","DOI":"10.1155\/2011\/294046","article-title":"Analysis of the pathogenesis of experimental autoimmune optic neuritis.","volume":"2011","author":"Kezuka","year":"2011","journal-title":"J Biomed Biotech"},{"key":"R2-10-20210126","first-page":"1717","article-title":"Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein.","volume":"33","author":"Potter","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-10-20210126","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1998.tb00194.x","article-title":"Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology.","volume":"8","author":"Storch","year":"1998","journal-title":"Brain Pathol"},{"key":"R4-10-20210126","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1167\/iovs.04-0554","article-title":"Myelinoligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL6 mouse.","volume":"45","author":"Shao","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-10-20210126","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1021\/jm050242f","article-title":"Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.","volume":"48","author":"Albert","year":"2005","journal-title":"J Med Chem"},{"key":"R6-10-20210126","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system.","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br J Pharmacol"},{"key":"R7-10-20210126","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.intimp.2010.10.005","article-title":"Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon- in mouse experimental autoimmune encephalomyelitis.","volume":"11","author":"Chiba","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"R8-10-20210126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1750-3639.2008.00182.x","article-title":"FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage.","volume":"19","author":"Foster","year":"2009","journal-title":"Brain Pathol"},{"key":"R9-10-20210126","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1167\/iovs.04-0541","article-title":"Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system.","volume":"45","author":"Prusky","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-10-20210126","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1167\/iovs.12-10559","article-title":"Visual functional and histopathological correlation in experimental autoimmune optic neuritis.","volume":"53","author":"Matsunaga","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-10-20210126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNO.0b013e31823c9b6c","article-title":"Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.","volume":"32","author":"Kezuka","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"R12-10-20210126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.","volume":"33","author":"Chun","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R13-10-20210126","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archneurol.2012.394","article-title":"Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies Effect of fingolimod on Schwann cells.","volume":"69","author":"Kohne","year":"2012","journal-title":"Arch Neurol"},{"key":"R14-10-20210126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis.","volume":"323","author":"Foster","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-10-20210126","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ajpath.2011.01.003","article-title":"Anti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritis.","volume":"178","author":"Rau","year":"2011","journal-title":"Am J Pathol"},{"key":"R16-10-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10633-008-9160-7","article-title":"Influence of narcotics on luminance and frequency modulated visual evoked potentials in rats.","volume":"118","author":"Jehle","year":"2009","journal-title":"Doc Ophthalmol"},{"key":"R17-10-20210126","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1167\/iovs.10-6005","article-title":"Simvastatin improves retinal ganglion cell survival and spatial vision after acute retinal ischemiareperfusion in mice.","volume":"52","author":"Krempler","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-10-20210126","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.2353\/ajpath.2010.091234","article-title":"Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.","volume":"176","author":"Miron","year":"2010","journal-title":"Am J Pathol"},{"key":"R19-10-20210126","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.0b013e318248deea","article-title":"Fingolimod-associated macular edema: incidence, detection, and management.","volume":"78","author":"Jain","year":"2012","journal-title":"Neurology"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e31828ea2fc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:44:55Z","timestamp":1620978295000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201306000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e31828ea2fc","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}